Introduction procedure, the posterior wall is preserved, maintaining the normal anatomy of the ear canal.
1 A third procedure may involve obliteration of the mastoid cavity by applying materials that effectively obliterate the cavity. A recent review by van der Toom et al 2 has shown recurrence rates as low as 4.6%
for both CWD and CWU with obliteration. Other studies suggest recurrence rates of 5 to 17% for CWD without obliteration, and as high as 9 to 70% for CWU without obliteration, 3 thus suggesting the use of obliteration in future surgeries. However, the published literature on recurrence is often based on studies with surgeries performed by some of the world's most experienced ear surgeons; consequently, these procedures have low recurrence rates, and the authors advocate a specific surgical approach. There may be an issue of publication bias. Moreover, when doing epidemiologic research on cholesteatoma, large cohorts and long follow-up times are needed. In Denmark, the opportunity for epidemiologic studies is unique due to a long tradition of collection of data on all inhabitants, 4 and the unique civil registration number assigned to all persons living in Denmark since 1968. 5 On the island of Funen, old medical records have been preserved, and they provide a unique opportunity to study the recurrence of cholesteatoma in a well-defined cohort with a long follow-up time.
The aim of the present study was to investigate the risk of recurrence after first-time surgically-treated middle-ear cholesteatoma (STMEC1) in a large, well-defined and unselected cohort with long follow-up, taking the surgical approach into consideration.
Materials and Methods
The Danish National Patient Register (NPR) was used for the identification of all patients with cholesteatoma surgery performed on the island of Funen in the period between January 1, 1983, and December 31, 2015.
All medical records from the identified patients were examined. For STMEC1, the date of hospitalization, the side of the ear, the surgical approach, any erosion of the posterior wall, any ossiculoplasty, and the date of recurrence were recorded.
Recurrence of cholesteatoma was defined as cholesteatoma in a subsequent surgery on the same ear. It proved impossible, by retrospective surgical chart review, to differentiate between a new cholesteatoma and a residual cholesteatoma, as well as to classify the cholesteatomas as flaccida or tensa cholesteatomas.
Patients without permanent residence in Denmark were excluded. Cases of congenital cholesteatomas and ear canal cholesteatomas were also excluded from the study.
Data on possible death or emigration to a foreign country were retrieved from the Patient Administrative System.
Possible surgery for recurrence elsewhere in Denmark was identified through the NPR, and, whenever possible, the relevant surgical charts were retrieved and included.
The surgical approaches were classified into 4 groups: 1 no mastoidectomy; 2 CWU without obliteration (CWU-obl);
3
CWU with obliteration (CWU þ obl); 4 and CWD.
Statistical Analyses
The Kaplan-Meier method and Cox regression analyses were applied.
In the analysis of recurrence, a second surgery for cholesteatoma on the same ear was considered an event, and the time since the first cholesteatoma surgery, as the underlying time variable. The ears were followed from the date of the first cholesteatoma surgery until the date of the second surgery (on Funen or elsewhere in Denmark), and censored at death, emigration to a foreign country, or due to end of follow-up (December 31, 2015), whichever came first. The interaction terms were tested by including them in the model.
Tests for violation of proportional hazards were performed using Schoenfeld residuals and log-log plot of survival. All statistical analyses were performed using the Stata (StataCorp, College Station, TX, US) software, version 14.
The analysis of the risk of contralateral disease was performed in a similar manner, with surgery on the opposite ear considered an event, and the time since cholesteatoma surgery on the first ear, as the underlying time variable.
The present study was approved by the Danish Data Protection Agency and the Danish Health Authorities.
Results
A total of 1,159 individuals had at least 1 cholesteatoma surgery registered in the NPR in the period between January 1, 1983, and December 31, 2015. the medical records were unavailable for 45 of these patients (3.9%). The medical records in the remaining 1,114 patients were reviewed, and 63 patients (5.7%) were found to have had had surgery before 1983 or at a department outside Funen, and were thus excluded. Of the remaining 1,051 patients, 2 (0.2%) were excluded as they did not have permanent residency in Denmark. Of the remaining 1,049 individuals, 34 (3.1%) had no cholesteatoma by medical record review, and they were excluded. Of the remaining 1,015 individuals, 2 were (0.2%) were excluded as it was impossible to determine the type of surgery based on the surgical chart.
Of the remaining 1,013 individuals with verified cholesteatoma, 55 (5.1%) had had cholesteatoma surgery on both ears, and there was a total of 1,068 ears with cholesteatoma. In these 1,068 ears, 5 (0.5%) of the cholesteatomas were found to be congenital, and 3 (0.3%) were found to be in the external ear canal. After excluding these 8 ears, the sample was composed of 1,060 ears of 1,006 patients (with 54 individuals with cholesteatoma surgery on both ears).
Of the 1,006 patients included, 25 (2,49%) had subsequent cholesteatoma surgery recorded on the NPR at a hospital outside of Funen. The medical records could be obtained for review in 18 cases, and recurrence was confirmed in 12 of them. In 7 patients, the medical records from outside Funen were unobtainable, and we assumed that the patients had undergone surgery for recurrence on the date registered on the NPR.
The median age at STMEC1 was 33 years, and the total observation time was of 12,049 years.
Of the 1,060 ears, 300 (28%) were children's (< 16 years) ears, and 760 (72%) were adult's ears. The number of ears included by time period and surgical approach is summarized in ►Table 1.
In children's ears 191 (64%) of the cholesteatomas were in male patients, and in adult's ears, 441 (58%) were in male patients.
Recurrence was found in 133 out of 300 children's ears (44%), and in 162 of 760 (21%) adult's ears.
Time-to-Event Analyses
►Fig. 1 demonstrates a much higher risk of recurrence in children compared with adults. After 5 years, an estimated 111 (37%) (95% confidence interval [95%CI]: 31-43%) of the children had had recurrence compared with 114 (15%) (95% CI: 13-18%) of adults, a rate that is 2.6 times higher.
Children
The rate of recurrence after 5 years (►Fig. 2) was lower in children without the need of mastoidectomy (23%; 95%CI: 16-32%), and higher in children with CWU-obl (58%; (95%CI: 45-71%). The rate of recurrence in cases of CWU þ obl was of 44% (95%CI: 35-55%) after 5 years.
The multivariate analysis (►Table 2) revealed a statistically higher risk of recurrence associated with CWU-obl compared with CWU þ obl (hazard ratio [HR]: 1.91; 95%CI: 1.20-3.02).
The HR for age at first surgery was of 0.93, that is, the older the child was at STEMC1, the risk of recurrence was reduced by 7% per year.
None of the defined time periods differed significantly from the baseline period. However, a clear trend of decrease in cholesteatoma recurrence with increasing time period was observed, and the test for trend revealed an HR of 0.96 (95%CI: 0.94-0.98; p < 0.001).
Adults
As in the group of children, in adults, the rate of recurrence was lower in the group with no mastoidectomy (12%; 95%CI: 8-16%) after 5 years, and higher in the group submitted to CWU-obl (20%; 95%CI: 14-29%) (►Fig. 3).
In adults, there was no significant difference in CWU-obl compared with CWU þ obl (►Table 3).
Cholesteatoma on Contralateral Ears
The risk of STMEC1 on the contralateral ear was higher in children (►Fig. 4) (6%; 95%CI: 3-9%) 5 years after STMEC1 on the first ear. This rate was of 8% (95%CI: 5-12%) 20 years after STMEC1 on the first ear. In adults, these numbers were 4% (95%CI: 3-6%) and 5% (95%CI: 4-8%) respectively.
Discussion
Our study showed that the overall risk of recurrence of cholesteatoma 5 years after primary surgery was 2.6 times higher in children compared with adults (38% versus 14% respectively). Moreover, the older the children were at the STMEC1, the risk decreased by 7% per year. This is in line with prior findings of high recurrence rates in children, [6] [7] [8] and may come from a better Eustachian tube function during childhood 9,10 which lowers the risk of negative middle ear pressure and retraction pockets, thus lowering the risk of a new cholesteatoma.
No mastoidectomy was associated with a considerably lower risk of recurrence in both children and adults. This was most likely because of less advanced cases of the disease and possibly because of the type of cholesteatoma.
In children, when mastoidectomy was performed, CWUobl was associated with a statistically significant higher risk of recurrence (HR: 1.9) compared with CWU þ obl. This supports the findings of other studies. [11] [12] [13] [14] [15] However, the patients in the present study were not randomized; thus, this association may also be the result of confounding factors. Factors such as location and extent of the cholesteatoma, the skill of the surgeon, as well as signs of infection, may all have influenced both the risk of recurrence and the choice to obliterate or not obliterate. Unfortunately, the data provided did not enable us to correct this. The material used for obliteration at that time on Funen was hydroxyapatite granule, and the obliteration was performed with the following technique: firstly, the mastoidectomy was performed using the canal wall up procedure, and the cholesteatoma was completely removed. Secondly, the mastoid and the middle ear were completely separated using cartilage and temporalis fascia, and the mastoid was tightly obliterated using hydroxy apatite granules, cortical bone chips and fibrin glue. Thirdly, ossicular reconstruction and myringoplasty with temporal fascia or cartilage were performed, thus restoring the ability to hear. Most recurrences occurred within 5 years after the primary surgery. However, there still was a considerable risk of recurrence after 5 years, and it could be argued that a 10-year follow-up period is appropriate in some cases.
The finding of cholesteatoma in the contralateral ear in 8% of the children and in 5% of the adults after 20 years of followup underscores the importance of checking the contralateral ear in individuals with cholesteatoma.
Strengths and Limitations
The present study has several strengths. Firstly, the study population encompassed a well-defined and unselected cohort. Secondly, the possibilities for the identification of patients and follow-up were exceptional due to the unique personal identification numbers, the preservation of medical records on Funen, the possibility to identify recurrence outside of Funen by the NPR, and the access to data on death and emigration to foreign countries in the patient administrative system. Thirdly, the analyses performed were appropriate time-to-event analyses. Lastly, the study population was large, and included both children and adults, as well as different surgical approaches, enabling direct comparisons.
The present study also has some limitations. Firstly, a major limitation was the lack of randomization combined with the lack of possibility to sufficiently adjust for parameters affecting the choice of surgical approach. An obvious result caused by confounding factors was the association between no mastoidectomy and a lower risk of recurrence. The underlying reason for the association between no obliteration and a lower risk of recurrence, which may also very well be a confounding factor, was more obscure. However, we considered unfeasible the possibility of conducting a study of this size, and especially with this follow-up time, as a prospective and randomized trial.
Secondly, there is the inherent risk of misclassification in the records. However, the medical records were reviewed, and all false positive cases in the NPR were excluded from the study. The completeness of the NPR has previously been estimated to be of 91% for STMEC1. 16 However, the number of cases missed due to this has previously been estimated to be limited. 17 Thirdly, the risk of individuals only undergoing one cholesteatoma surgery not being registered in the NPR is greater than the risk for individuals undergoing several cholesteatoma surgeries. This may have slightly increased the estimated risk of recurrence. Lastly, it proved impossible to differentiate between a new cholesteatoma and a residual cholesteatoma, as well as to classify the cholesteatomas as flaccida or tensa cholesteatomas in the present retrospective study.
Conclusion
In the present study, which included 1,006 patients and a total observation time of 12,049 years, we found that, compared with adults, children had 2.6 times more risk of recurrence. The older the child was at the first surgery, the risk decreased by 7% per year.
Ears without the need of mastoidectomy had the lowest risk of recurrence. In children treated with CWU, obliteration was associated with a risk of recurrence that was significantly lower than that of no obliteration. However, the patients were not randomized with regards to surgical approach, and the demonstrated association between surgical approach and risk of recurrence was likely influenced by confounding factors.
The estimated rate of cholesteatoma surgery on the contralateral ear 5 years after cholesteatoma surgery on the first ear was of 6% in children and of 4% in adults.
The high risk of recurrence and a considerable risk of a subsequent cholesteatoma on the contralateral ear underscore the importance of follow-up after cholesteatoma surgery.
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